2 citations
,
November 2023 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This review discusses the use of platelet-rich plasma in aesthetic treatments, emphasizing its benefits and potential as a promising and safe alternative for enhancing appearance and self-confidence, without presenting new clinical results.
2 citations
,
November 2022 in “Brazilian Journal of Health Review” This source reports that hair transplant surgery can lead to permanent hair growth improvements for men with androgenetic alopecia, and continuing minoxidil or finasteride after the procedure may reduce further hair loss.
1 citations
,
January 2024 in “Surgical & Cosmetic Dermatology” In this study, complete recovery from folliculitis dissecans was observed after intradermal botulinum toxin A injections, with the effect attributed to the host response rather than direct bacterial action.
1 citations
,
November 2022 in “PubVet” This case study describes using microneedling combined with orchiectomy as a treatment for alopecia X in a male German Spitz dog, highlighting this approach for managing the condition.
1 citations
,
January 2021 in “Research, Society and Development” This study reviewed literature on using vegetable oils to prevent skin aging, highlighting their antioxidant properties and their role in combating free radicals, which leads to extrinsic aging, while also noting Brazil's important contribution to this field with its rich natural resources.
1 citations
,
January 2014 Some drugs can cause temporary or permanent hair loss.
July 2026 in “Research Society and Development” This study reviewed recent advancements in treating androgenetic alopecia, reporting that while minoxidil and 5-alpha-reductase inhibitors remain well-supported treatments, emerging therapies like microneedling, platelet-rich plasma, low-level laser, and regenerative medicine show promising complementary results.
February 2026 in “Revista Eletrônica Polidisciplinar Voos.” In this integrative narrative review, researchers reported that aromatase inhibition using dutasteride and Serenoa repens after hair transplant can effectively preserve follicles and minimize side effects, suggesting personalized strategies may optimize clinical outcomes and patient satisfaction.
January 2026 in “Magazine Portal Bibliotech Digital (Universidad Nacional de Colombia)” This study reviewed the literature on Minoxidil and finasteride for androgenetic alopecia, finding both drugs effective but noting potential side effects, with combined therapy possibly enhancing efficacy and patient adherence while reducing adverse effects.
December 2025 in “Revista fisio&terapia.” This study found that androgenetic alopecia treatments, especially dutasteride, are associated with a small increased risk of adverse events like sexual dysfunction and dermatologic reactions.
November 2025 in “Revista Multidisciplinar do Nordeste Mineiro” This study's review of existing literature suggests potential benefits of red LED photobiomodulation for treating telogen effluvium, but highlights a lack of standardized parameters and calls for further controlled trials.
November 2025 in “Contribuciones a las Ciencias Sociales” This study reported that a patient with androgenetic alopecia experienced significant improvements in hair density, thickness, and vitality using non-pharmacological approaches such as dietary adjustments, exercise, and supplementary treatments like low-level laser therapy and microneedling, suggesting these may be effective alternative management strategies.
November 2025 in “Revista Foco” This study reviewed the effectiveness and safety of Minoxidil for treating alopecia and found that concentrations of 2% to 5% effectively promoted hair growth, especially when combined with other therapies like microneedling, despite manageable local side effects.
October 2025 in “Open Repository of the University of Porto (University of Porto)” October 2025 in “Open Repository of the University of Porto (University of Porto)” October 2025 in “Open Repository of the University of Porto (University of Porto)”
October 2025 in “Scientia Generalis” In this narrative review, dysbiosis was found to potentially influence androgen metabolism and immune response, suggesting that gut microbiota balance may play a role in the prevention and treatment of androgenetic and areata alopecia.
September 2025 in “Editora Pasteur eBooks” Low-dose oral minoxidil is as effective as or better than topical minoxidil for hair growth but may cause mild side effects.
This study detailed a comprehensive hair therapy regimen for a 22-year-old male with androgenetic alopecia, observing significant improvements in scalp health and hair density over four months, though benefits regressed after stopping treatment, emphasizing the need for continuous adherence and multidisciplinary support.
August 2025 in “SciELO (SciELO Preprints)” In this review, the authors assessed the efficacy of mesotherapy for alopecia treatment, finding that combining mesotherapy with minoxidil, PRP, or growth factors significantly improves hair density and thickness but noted the need for standardized protocols and larger studies to confirm long-term effectiveness.
July 2025 in “Revista Eletrônica Acervo Científico” This integrative literature review found that hydroxychloroquine may stabilize inflammatory scarring autoimmune alopecias like frontal fibrosing alopecia, especially when combined with other therapies, while its effectiveness in non-scarring alopecias appears inconsistent and is limited to refractory cases.
May 2025 in “RCMOS - Revista Científica Multidisciplinar O Saber” This study, through a review of existing literature, observed that massage techniques may serve as a beneficial complementary therapy for male androgenetic alopecia by enhancing blood circulation and overall follicle nutrition, with combined approaches possibly increasing treatment efficacy despite a lack of standardized protocols.
April 2025 in “Revista de Ciências da Saúde Nova Esperança” This review discusses the various therapeutic uses of Botulinum Toxin Type A and reports high levels of patient satisfaction with minimal adverse effects across several conditions, emphasizing its potential therapeutic importance.
April 2025 in “Journal of Medical Residency Review” This review examined the use of platelet-rich plasma in aesthetic skin rejuvenation and found promising results when combined with other treatments, but limited efficacy when used alone.
This study concluded that phytotherapy offers a potentially effective and safer alternative to conventional treatments for androgenetic alopecia by reducing hair loss progression without the usual adverse effects.
January 2025 in “Lume (Universidade Federal do Rio Grande do Sul)” This study found that 51.1% of healthcare professionals with confirmed COVID-19 reported dermatological symptoms, with hair loss being the most common, and highlighted a potential link between prophylactic vitamin D use and red papule skin lesions that warrants further investigation.
December 2024 in “Caderno Pedagógico” This review found limited scientific evidence on the importance of scalp health for successful hair transplants, with most care recommendations based on surgeons' opinions.
November 2024 in “Open Repository of the University of Porto (University of Porto)” This report details a six-month internship experience, split between hospital and community pharmacy settings, which enhanced practical skills and theoretical knowledge in pharmaceutical care and highlighted the pharmacist's role in ensuring safe medication use.
October 2024 in “Open Repository of the University of Porto (University of Porto)” In this report, the author shares experiences from a six-month curricular internship, highlighting activities such as arterial pressure monitoring in a community pharmacy and addressing off-label rituximab use at a hospital, alongside discussions of hair loss treatments and nutritional supplementation for dysphagia in the elderly.
May 2024 in “International Seven Multidisciplinary Journal” This study reviewed the literature to explore the dermatological symptoms associated with Polycystic Ovary Syndrome, such as hirsutism and acne, highlighting the importance of a multidisciplinary approach for optimal management of the syndrome, including controlling circulating androgen levels.